TY - JOUR
T1 - Multi-modal MR imaging and magnetic hyperthermia study of Gd doped Fe3O4 nanoparticles for integrative cancer therapy
AU - Thorat, Nanasaheb D.
AU - Bohara, Raghvendra A.
AU - Yadav, Hemraj M.
AU - Tofail, Syed A.M.
N1 - Publisher Copyright:
© 2016 The Royal Society of Chemistry.
PY - 2016
Y1 - 2016
N2 - Among different kinds of cancer theranostic mediators, gadolinium (Gd) doped iron oxide nanoparticles are one of the most promising candidates in combining diagnostics (imaging) and therapeutics (molecular therapy) functions in a single, multimodal platform. Due to its larger size, the doping of Gd into the Fe3O4 is difficult. We have overcome this difficulty by modifying a polyol based reflux method that has been previously used for, for example, cobalt-zinc (Co-Zn) doping of ferrites but not for doping with Gd. This modified approach allowed a facile synthesis of Gd-doped superparamagnetic iron oxide (Fe3O4) nanoparticles (GdSPIONPs) with a lower Curie temperature (Tc) for hyperthermia superparamagnetism with low coercivity, both T1 and T2 based MRI contrast enhancements, low cytotoxicity and optimal hemocompatibility. Such a combination of theranostics properties in a single nanosystem is unprecedented and highly desirable for heat controlled magnetic hyperthermia in minimizing treatment resistance, and maximizing treatment efficacy.
AB - Among different kinds of cancer theranostic mediators, gadolinium (Gd) doped iron oxide nanoparticles are one of the most promising candidates in combining diagnostics (imaging) and therapeutics (molecular therapy) functions in a single, multimodal platform. Due to its larger size, the doping of Gd into the Fe3O4 is difficult. We have overcome this difficulty by modifying a polyol based reflux method that has been previously used for, for example, cobalt-zinc (Co-Zn) doping of ferrites but not for doping with Gd. This modified approach allowed a facile synthesis of Gd-doped superparamagnetic iron oxide (Fe3O4) nanoparticles (GdSPIONPs) with a lower Curie temperature (Tc) for hyperthermia superparamagnetism with low coercivity, both T1 and T2 based MRI contrast enhancements, low cytotoxicity and optimal hemocompatibility. Such a combination of theranostics properties in a single nanosystem is unprecedented and highly desirable for heat controlled magnetic hyperthermia in minimizing treatment resistance, and maximizing treatment efficacy.
UR - http://www.scopus.com/inward/record.url?scp=84991216593&partnerID=8YFLogxK
U2 - 10.1039/c6ra20135k
DO - 10.1039/c6ra20135k
M3 - Article
AN - SCOPUS:84991216593
SN - 2046-2069
VL - 6
SP - 94967
EP - 94975
JO - RSC Advances
JF - RSC Advances
IS - 97
ER -